Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06580041
PHASE4

Precision Care for Major Depressive Disorder

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

This study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-11-12

Completion Date

2029-09-01

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

DRUG

Pramipexole

CAU plan modified to include a trial of pramipexole.

DRUG

Methylphenidate

CAU plan modified to include a trial of methylphenidate (or, if contraindicated: guanfacine).

DRUG

Phenelzine

CAU plan modified to include a trial of phenelzine (or, if contraindicated: brexpiprazole).

BEHAVIORAL

Mindfulness-based Stress Sensitivity Therapy (MBSST)

CAU plan modified to include a trial of MBSST. MBSST is an individual psychotherapy delivered approximately weekly for 16 sessions.

BEHAVIORAL

Complicated Grief Treatment (CGT)

CAU plan modified to include a trial of CGT.

OTHER

Care as usual (CAU) plan

Unmodified CAU plan.

Locations (1)

Nancy Friend Pritzker Psychiatry Building, University of California, San Francisco

San Francisco, California, United States